Skip to content
★ Sign in to follow
JS Link, Inc. logo

JS Link, Inc. Stock: price and insider trades · South Korea

제이에스링크

KR·Mcap ₩633.3BHealth Care

No insider purchase over the last 90 days. The latest, by 국민연금공단, was filed 01 Jul 2026.

JS Link, Inc.: what insiders have been doing

JS Link, Inc. is a Health Care company. Its directors and officers file their transactions with DART (FSS). The last twelve months, up to 2 November 2026, brought 27 filings signed by 6 insiders.

Open-market activity splits into 25 purchases and 1 sale; 5 insiders sit on the buying side and 1 insider on the selling side. The totals do not cover 26 filings with an undisclosed amount. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Those buying include 3 board members and 2 major shareholders.

Compared with its exchange (2,655 companies, median 7 filings), a count of 27 filings is above the norm. Our records for JS Link, Inc. go back to 2021, with 53 purchases and 2 sales on the open market in total.

The last purchase on record was published on 1 July 2026, which is 131 days ago. The median gap between a trade and its publication by DART (FSS) is 5 days. This delay matters because a trade only becomes useful information once it is public.

Other companies in the same sector with recent insider buying flagged by our signals: Dynavox Group AB and UCB. These figures are compiled from regulatory filings published by DART (FSS). They describe what insiders did and are not a recommendation.

Insider Decl.
87
Thresholds
n/a
Buy Volume
€205M
53 ops. · all time
Sell Volume
€9M
2 ops. · all time

Who traded when

BuySale
주성씨앤에어26 buys1 sale
박진수2 buys
국민연금공단1 buy
김선진1 buy
박규석1 buy

Since the insiders bought

  • Filed 22 Apr 2026 · 201 days ago · €1.3M
    -58.8%
    Entry ₩44,200 · Close 30 Oct 2026 ₩18,230
  • Filed 06 Apr 2026 · 217 days ago · €22.5M
    -54.5%
    Entry ₩40,050 · Close 30 Oct 2026 ₩18,230
  • Filed 06 Apr 2026 · 217 days ago · €622k
    -54.5%
    Entry ₩40,050 · Close 30 Oct 2026 ₩18,230

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Fundamental score
Ranked 24,979 of 26,913 companies
18.4
score / 100
Value
21
Quality
15
FCF yld-8.8%
Earn yld-2.7%
EV/EBITDA·
ROE-7.4%
Gross mgn19%
Net mgn-85%
Debt/EBITDA·
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended December 2025 · cache

₩18,230
Analyst consensus
·
Income statement
Revenue₩19.3B
Gross profit₩3.6B19% margin
EBITDA-₩11.5B-60% margin
Net income-₩16.4B-23.3% margin
Valuation
Beta0.58
Balance sheet & cash
Market cap₩633.3B
Total debt₩43.3B
Free Cash Flow-₩53.5B
Debt / Equity61%
Profitability & ownership
ROE-7.4%
ROA-8.3%
% insiders27.1%
% institutions2.5%
Last declaration on 1 July 2026
Declarations95 total
  • Other
    Other(filed)
    0DART
  • Other
    Other(filed)
    0DART
  • Other
    Other(filed)
    0DART
  • Other
    Other(filed)
    0DART
  • Other
    Other(filed)
    0DART
  • Other
    Other(filed)
    0DART
  • Other
    Other(filed)
    0DART
  • Other
    Other(filed)
    0DART
  • ▲
    대량보유자Executives(filed)
    €35.9Mest.0DART
    1,755,928 sharesKRXDART:20260701000175
    Canonical exit: 29 Sept 2026 (T+90)
  • ▲
    대량보유자Executives(filed)
    €8.5Mest.0DART
    412,781 sharesKRXDART:20260629000163
    Canonical exit: 27 Sept 2026 (T+90)
  • ▲
    10%이상주주Executives(filed)
    €5.8Mest.0DART
    280,804 sharesShareKRXDART:20260629000161
    Canonical exit: 27 Sept 2026 (T+90)
  • ▲
    사외이사Executives
    €1.3Mest.0DART
    58,555 sharesShareKRXDART:20260422000356
    Canonical exit: 29 Jun 2026 (T+90)
  • ▲
    Executives
    €22.5Mest.0DART
    969,428 sharesKRXDART:20260406004322
    Canonical exit: 30 Jun 2026 (T+90)
  • ▲
    사외이사Executives
    €622kest.0DART
    28,488 sharesShareKRXDART:20260406003452
    Canonical exit: 29 Jun 2026 (T+90)
  • ●
    Executives
    Executives(filed)
    0DART
  • ▼
    Executives
    €8.7Mest.0DART
    375,798 sharesKRXDART:20260227007413
  • ▲
    -Executives(filed)
    €3.0Mest.0DART
    183,131 sharesShareKRXDART:20260209000476
    Canonical exit: 10 May 2026 (T+90)
  • ▲
    Executives
    €3.0Mest.0DART
    183,131 sharesKRXDART:20260209000507
    Canonical exit: 4 May 2026 (T+90)
  • ▲
    -Executives(filed)
    €130kest.0DART
    12,060 sharesShareKRXDART:20260107000004
    Canonical exit: 7 Apr 2026 (T+90)
  • ▲
    Executives
    €130kest.0DART
    12,060 sharesKRXDART:20260107000003
    Canonical exit: 6 Apr 2026 (T+90)
  • ▲
    Executives
    €118kest.0DART
    11,750 sharesKRXDART:20260105000003
    Canonical exit: 2 Apr 2026 (T+90)
  • ▲
    -Executives(filed)
    €118kest.0DART
    11,750 sharesShareKRXDART:20260105000004
    Canonical exit: 5 Apr 2026 (T+90)
  • ▲
    -Executives(filed)
    €12kest.0DART
    1,070 sharesShareKRXDART:20251229000017
    Canonical exit: 29 Mar 2026 (T+90)
  • ▲
    Executives
    €151kest.0DART
    13,220 sharesKRXDART:20251229000016
    Canonical exit: 22 Mar 2026 (T+90)
  • ▲
    Executives
    €136kest.0DART
    13,664 sharesKRXDART:20251217000002
    Canonical exit: 16 Mar 2026 (T+90)

25 of 95 declarations

About JS Link, Inc.

제이에스링크 is a company operating in the healthcare and pharmaceutical sector, listed on the XKRX market. It specializes in the development and distribution of pharmaceutical products.

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations